Correlation Between Neumora Therapeutics, and Ihuman

Can any of the company-specific risk be diversified away by investing in both Neumora Therapeutics, and Ihuman at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neumora Therapeutics, and Ihuman into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neumora Therapeutics, and Ihuman Inc, you can compare the effects of market volatilities on Neumora Therapeutics, and Ihuman and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neumora Therapeutics, with a short position of Ihuman. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neumora Therapeutics, and Ihuman.

Diversification Opportunities for Neumora Therapeutics, and Ihuman

-0.33

Correlation Coefficient

Neumora Therapeutics,  Ihuman

Very good diversification

The 3 months correlation between Neumora and Ihuman is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Neumora Therapeutics, and Ihuman Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ihuman Inc and Neumora Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neumora Therapeutics, are associated (or correlated) with Ihuman. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ihuman Inc has no effect on the direction of Neumora Therapeutics, i.e., Neumora Therapeutics, and Ihuman go up and down completely randomly.

Pair Corralation between Neumora Therapeutics, and Ihuman

Given the investment horizon of 90 days Neumora Therapeutics, is expected to under-perform the Ihuman. In addition to that, Neumora Therapeutics, is 2.18 times more volatile than Ihuman Inc. It trades about -0.2 of its total potential returns per unit of risk. Ihuman Inc is currently generating about 0.13 per unit of volatility. If you would invest  172.00  in Ihuman Inc on December 27, 2024 and sell it today you would earn a total of  67.00  from holding Ihuman Inc or generate 38.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neumora Therapeutics,  vs.  Ihuman Inc

Neumora Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neumora Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Ihuman Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ihuman Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Ihuman demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neumora Therapeutics, and Ihuman

The main advantage of trading using opposite Neumora Therapeutics, and Ihuman positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neumora Therapeutics, position performs unexpectedly, Ihuman can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ihuman will offset losses from the drop in Ihuman's long position.

The idea behind Neumora Therapeutics, and Ihuman Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.